Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwang Hyub Han

Showing results (241-250 of 527) with videos related to

Pageof 53
Sort By:
Journal of Medical Virology|October 28, 2017
Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistanceDong Yun Kim, Hye Won Lee, Jeong Eun Song, et al.
Intervirology|November 13, 2008
Clinical course of virologic breakthrough after emergence of YMDD mutations in HBeAg-positive chronic hepatitis BDo Young Kim, Sang Hoon Ahn, Hyun Woong Lee, et al.
Cancer|May 18, 2007
Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinomaJun Yong Park, Sang Hoon Ahn, Young Joon Yoon, et al.
Digestive Diseases and Sciences|April 30, 2010
Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitisMyoung Hee Lee, Jae Youn Cheong, Soon Ho Um, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2010
Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinomaBeom Kyung Kim, Sang Hoon Ahn, Jin Sil Seong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2012
Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolizationBeom Kyung Kim, Seung Up Kim, Myeong-Jin Kim, et al.
Clinical and Molecular Hepatology|November 14, 2018
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovirDavid Sooik Kim, Mi Young Jeon, Hye Won Lee, et al.
Hepatology (Baltimore, Md.)|February 4, 2015
Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosisMi Na Kim, Seung Up Kim, Beom Kyung Kim, et al.
World Journal of Gastroenterology|January 30, 2015
Factors associated with significant liver fibrosis assessed using transient elastography in general populationSeng Chan You, Kwang Joon Kim, Seung Up Kim, et al.
Clinical and Molecular Hepatology|December 15, 2020
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis BMi Young Jeon, Beom Kyung Kim, Jae Seung Lee, et al.
Pageof 53

Showing results (241-250 of 527) with videos related to

Sort By:
Pageof 53
Journal of Medical Virology|October 28, 2017
Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistanceDong Yun Kim, Hye Won Lee, Jeong Eun Song, et al.
Intervirology|November 13, 2008
Clinical course of virologic breakthrough after emergence of YMDD mutations in HBeAg-positive chronic hepatitis BDo Young Kim, Sang Hoon Ahn, Hyun Woong Lee, et al.
Cancer|May 18, 2007
Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinomaJun Yong Park, Sang Hoon Ahn, Young Joon Yoon, et al.
Digestive Diseases and Sciences|April 30, 2010
Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitisMyoung Hee Lee, Jae Youn Cheong, Soon Ho Um, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2010
Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinomaBeom Kyung Kim, Sang Hoon Ahn, Jin Sil Seong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2012
Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolizationBeom Kyung Kim, Seung Up Kim, Myeong-Jin Kim, et al.
Clinical and Molecular Hepatology|November 14, 2018
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovirDavid Sooik Kim, Mi Young Jeon, Hye Won Lee, et al.
Hepatology (Baltimore, Md.)|February 4, 2015
Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosisMi Na Kim, Seung Up Kim, Beom Kyung Kim, et al.
World Journal of Gastroenterology|January 30, 2015
Factors associated with significant liver fibrosis assessed using transient elastography in general populationSeng Chan You, Kwang Joon Kim, Seung Up Kim, et al.
Clinical and Molecular Hepatology|December 15, 2020
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis BMi Young Jeon, Beom Kyung Kim, Jae Seung Lee, et al.
Pageof 53